![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-5299|1|6|555-566
ISSN: 1568-007X
Source: Current Drug Targets-CNS & Neurological Disorders, Vol.1, Iss.6, 2002-12, pp. : 555-566
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Neuropeptides as Therapeutic Targets in Anxiety Disorders
Current Pharmaceutical Design, Vol. 18, Iss. 35, 2012-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Possible Therapeutic Targets in Cardiac Myocyte Apoptosis
Current Pharmaceutical Design, Vol. 10, Iss. 20, 2004-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Novel Therapeutic Targets in Neuropsychiatric Disorders: The Neuroepigenome
Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. :